Immunizations

Seqirus expects to supply up to 60 million doses of influenza vaccines for healthcare providers in the United States.

Industry organizations are signaling that pharmacy can play a critical role in actually administering the millions of COVID-19 vaccine doses needed to curb the pandemic. 

GSK will supply more than 50 million doses of its influenza vaccines for the U.S. market during the 2020-2021 season, an increase from 46 million during the 2019-2020 influenza season.

The Department of Health and Human Services’ agreement with Pfizer for the production of 100 million doses of a COVID-19 vaccine allows the U.S. government to acquire an additional 500 million doses.

The National Association of Chain Drug Stores’ board of directors recently took the case of pharmacy's role in responding to COVID-19 to the Department of Health and Human Services assistant secretary for health, Adm. Brett Giroir.

Through RedSail 's Advantage program, pharmacies can sign up for clinical services from OmniSys that can help build new revenue streams.

The International Pharmaceutical Federation is offering a free resource to pharmacists, which includes practical guidance on implementing a vaccination service.

The National Association of Chain Drug Stores and 12 national pharmacy groups are requesting clarity from the Department of Health and Human Services surrounding pharmacists’ vaccination authority under the PREP Act.